Acadian Asset Management LLC Has $6.99 Million Position in Alignment Healthcare, Inc. $ALHC

Key Points

• Acadian Asset Management increased its stake in Alignment Healthcare by 1,025.2%, acquiring 342,537 additional shares, bringing its total ownership to 375,949 shares valued at approximately $6.99 million.
• Analysts have recently upgraded their ratings and target prices for Alignment Healthcare, with Barclays raising the target from $9 to $13, and KeyCorp setting a new target of $21.
• Insider trading activity includes significant sales by CEO John E. Kao and insider Robert L. Scavo, reducing their respective holdings by 7.26% and 4.91%.

Acadian Asset Management LLC increased its position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 1,025.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 375,949 shares of the company's stock after buying an additional 342,537 shares during the quarter. Acadian Asset Management LLC owned about 0.19% of Alignment Healthcare worth $6,992,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Wellington Management Group LLP raised its position in Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the period. Millennium Management LLC raised its position in Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after purchasing an additional 2,896,311 shares during the period. Point72 Asset Management L.P. purchased a new position in Alignment Healthcare in the fourth quarter valued at about $20,087,000. Invesco Ltd. grew its stake in shares of Alignment Healthcare by 1,415.7% during the first quarter. Invesco Ltd. now owns 1,875,790 shares of the company's stock valued at $34,927,000 after acquiring an additional 1,752,033 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock valued at $206,941,000 after acquiring an additional 1,295,825 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ALHC shares. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Finally, KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a research note on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 215,662 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the transaction, the president directly owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. The trade was a 10.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $17.00, for a total transaction of $425,000.00. Following the transaction, the director owned 1,127,049 shares in the company, valued at approximately $19,159,833. The trade was a 2.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,142,077 shares of company stock valued at $18,068,259 in the last 90 days. 7.00% of the stock is owned by corporate insiders.

Alignment Healthcare Stock Performance

Shares of ALHC traded down $0.35 during mid-day trading on Thursday, reaching $16.34. 1,322,283 shares of the company's stock traded hands, compared to its average volume of 3,115,910. The business's 50-day moving average price is $14.58 and its 200-day moving average price is $15.56. The stock has a market capitalization of $3.23 billion, a P/E ratio of -58.32 and a beta of 1.17. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. Alignment Healthcare, Inc. has a 12 month low of $9.15 and a 12 month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business's revenue for the quarter was up 49.0% on a year-over-year basis. During the same quarter last year, the business earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.